The Cooper Companies, Inc. Common Stock

Cooper Companies trades at a P/E of 30.31 while its RSI sits at just 27.3—a notable divergence suggesting the stock has experienced significant selling pressure despite maintaining a premium valuation. The 3.23% short interest remains modest, so there's minimal squeeze potential here. Trading well below its 52-week high, the ophthalmic goods specialist appears caught between two narratives: the market has punished it enough to create oversold technical conditions, yet the elevated multiple implies either recovery expectations or valuation stickiness. This setup creates ambiguity about whether the weakness reflects fundamental concerns or a capitulation bottom worth monitoring closely.